Takeda Pharmaceutical Co TAKP34 Income Statements

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
Brazil
BOV
Takeda Pharmaceutical Co (TAKP34)
Takeda Pharmaceutical Co (TAKP34) Financials

Takeda Pharmaceutical Co (TAKP34)

69.86

2.78

(4.14%)

Closed June 01 4:55PM

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly

Quarter End	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)
Total Revenue	977.94B	1.01T	1.1T	962.81B	1.06T	1.05T	1.11T	1.06T
Operating Income	150.02B	103.57B	145.22B	85.67B	168.15B	-47.32B	106.04B	-6.33B
Pre Tax Income	155.47B	64.55B	107.15B	47.92B	135.03B	-95.98B	61.26B	-47.52B
Net Income	105.01B	61.74B	119.13B	31.13B	89.4B	-48.03B	105.72B	-3.02B
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	150.02B	103.57B	145.22B	87.76B	168.15B	-47.32B	106.04B	-6.33B
EBITDA	439.58B	413.76B	457.68B	380.3B	469.08B	375.62B	430.44B	325.53B

Year End March 30 2024	2017	2018	2019	2020	2021	2022	2023	2024
	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)	JPY (¥)
Total Revenue	1.73T	1.77T	2.15T	3.35T	3.28T	3.61T	4.05T	4.28T
Operating Income	83.67B	166.73B	58.4B	70.72B	275.69B	438.73B	479.78B	220.55B
Pre Tax Income	143.35B	217.21B	94.9B	-60.75B	366.24B	302.57B	375.09B	52.79B
Net Income	114.94B	186.89B	109.13B	44.24B	376.01B	230.06B	317.02B	144.07B
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	145.398	235.169	69.729	28.065	238.523	145.4	200.353	91.044
EBIT	1.29B	47.38B	108.73B	73.87B	280.42B	439.88B	481.88B	220.55B
EBITDA	463.17B	470.99B	534.22B	1.11T	1.26T	1.49T	1.69T	1.6T

Takeda Pharmaceutical

CAC Consumer Discretionary

BNP Paribas Issuance

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions